Cargando…
MUC16:肿瘤治疗新靶点
Mucin16 (MUC16), also known as carbohydrate antigen 125 (CA125), is a glycoprotein antigen that can be recognized by the monoclonal antibody OC125 detected from epithelial ovarian carcinoma antigen by Bast et al in 1981. CA125 is not present in normal ovarian tissue but is usually elevated in the se...
Formato: | Online Artículo Texto |
---|---|
Lenguaje: | English |
Publicado: |
中国肺癌杂志编辑部
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9346149/ https://www.ncbi.nlm.nih.gov/pubmed/35899441 http://dx.doi.org/10.3779/j.issn.1009-3419.2022.101.31 |
Ejemplares similares
-
肺癌靶向治疗和免疫治疗药物临床试验现场核查关注点探讨
Publicado: (2022) -
罕见肿瘤新药研发的思考
Publicado: (2022) -
自身抗体预后标志物在肿瘤免疫检查点抑制剂治疗中的临床价值
Publicado: (2022) -
非小细胞肺癌新辅助免疫治疗进展
Publicado: (2022) -
境外授权许可引进抗肿瘤新药临床研发策略的审评考虑
Publicado: (2022)